Rodney Young
Director of Finance/CFO presso RAPT THERAPEUTICS, INC.
Patrimonio netto: 105 353 $ in data 31/03/2024
Posizioni attive di Rodney Young
Società | Posizione | Inizio | Fine |
---|---|---|---|
RAPT THERAPEUTICS, INC. | Director of Finance/CFO | 02/12/2019 | - |
Corporate Secretary | 02/12/2019 | - |
Storia della carriera di Rodney Young
Precedenti posizioni note di Rodney Young
Società | Posizione | Inizio | Fine |
---|---|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Director of Finance/CFO | 16/06/2015 | 01/11/2019 |
AIMMUNE THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2014 | 01/02/2015 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Director of Finance/CFO | 01/09/2005 | 01/12/2013 |
Investor Relations Contact | 01/09/2005 | 01/12/2013 | |
Public Communications Contact | - | 01/12/2013 | |
Extropy Pharmaceuticals, Inc. | Director of Finance/CFO | 01/01/2003 | 01/01/2005 |
Formazione di Rodney Young
The University of Chicago | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Director of Finance/CFO | 5 |
Undergraduate Degree | 1 |
Investor Relations Contact | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
RAPT THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Extropy Pharmaceuticals, Inc. | |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Borsa valori
- Insiders
- Rodney Young
- Esperienza